Name | somatostatin |
---|---|
Synonyms |
growth hormone inhibiting hormone
15-28-Somatostatin-28 Modustatina SS-14 L-Alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10-[(1S)-1-hydroxyethyl]-16-(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide Somatostatin Acetate Somatofalk MFCD00076762 Stilamin GH-RIF SRIF-A somatotropin release inhibiting factor L-Alanylglycyl-L-cysteinyl-L-lysyl-L-asparaginyl-L-phenylalanyl-L-phenylalanyl-L-tryptophyl-L-lysyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-cysteine Cyclic (3®14) Disulfide SRIF Somatostatin Somatostatina EINECS 256-969-7 Aminopan L-Alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide Glycinamide, L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-4-carboxy-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-13,25,28-tris(phenylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacont-37-yl]- Glycinamide, L-alanyl-N-[(4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-4-carboxy-10-[(1S)-1-hydroxyethyl]-16-(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-13,25,28-tris(phenylmethyl)-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacont-37-yl]- ALA-GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS: AGCKNFFWKTFTSC DISULFIDE BRIDGE CYS3-CYS14 Cyclic somatostatin |
Description | Cyclic somatostatin is a growth hormone-release inhibiting factor used in the treatment of severe, acute hemorrhages of gastroduodenal ulcers. Sequence: H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bridge: Cys3-Cys14). |
---|---|
Related Catalog |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 1970.9±65.0 °C at 760 mmHg |
Molecular Formula | C76H104N18O19S2 |
Molecular Weight | 1637.878 |
Flash Point | 1145.7±34.3 °C |
Exact Mass | 1636.716675 |
PSA | 663.83000 |
LogP | -4.25 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.670 |
Storage condition | −20°C |
Water Solubility | H2O: 1 mg/mL | Soluble in water(25,00°C 1,00 g/L), Methanol. |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | WF8751700 |
~95% 38916-34-6 |
Literature: Kitada, Shingo; Takahashi, Masahito; Yamaguchi, Yusuke; Okada, Yohei; Chiba, Kazuhiro Organic Letters, 2012 , vol. 14, # 23 p. 5960 - 5963 |
~% 38916-34-6 |
Literature: Shi, Tiesheng; Rabenstein, Dallas L. Journal of Organic Chemistry, 1999 , vol. 64, # 13 p. 4590 - 4595 |
Precursor 1 | |
---|---|
DownStream 0 |